How I treat advanced Hodgkin lymphoma - a global view
- PMID: 32557589
- PMCID: PMC7116450
- DOI: 10.1111/bjh.16587
How I treat advanced Hodgkin lymphoma - a global view
Conflict of interest statement
There are no conflicts to declare.
Comment in
-
Correspondence in reference to the previously published Epub manuscript: "Peter Hokland, et al. How I treat advanced Hodgkin lymphoma - a global view. British Journal of Haematology 2020; 190: 837-850." - RESPONSE.Br J Haematol. 2021 Apr;193(1):e4-e5. doi: 10.1111/bjh.17370. Epub 2021 Feb 22. Br J Haematol. 2021. PMID: 33617674 No abstract available.
-
Correspondence in reference to the previously published Epub manuscript by Peter Hokland et al. 'How I treat advanced Hodgkin lymphoma - a global view'. Br J Haematol. 2020;190:837-50.Br J Haematol. 2021 Apr;193(1):e5-e8. doi: 10.1111/bjh.17371. Epub 2021 Mar 4. Br J Haematol. 2021. PMID: 33660274 No abstract available.
Similar articles
-
[Therapy of Hodgkin lymphoma: chances of remission are good, treatment tolerance needs improvement].MMW Fortschr Med. 2011 Oct 13;153(41):17. doi: 10.1007/BF03368883. MMW Fortschr Med. 2011. PMID: 22046834 German. No abstract available.
-
Report of satellite workshop on interim-PET in Hodgkin lymphoma: 8th International Symposium on Hodgkin Lymphoma, Cologne, 23 October 2010.Leuk Lymphoma. 2011 Apr;52(4):583-6. doi: 10.3109/10428194.2010.551162. Leuk Lymphoma. 2011. PMID: 21438829 Review. No abstract available.
-
Omitting radiotherapy after attaining FDG PET-negative status following chemotherapy alone for Hodgkin lymphoma: a randomized study caveat.Leuk Lymphoma. 2007 Sep;48(9):1667-9. doi: 10.1080/10428190701606875. Leuk Lymphoma. 2007. PMID: 17786699 No abstract available.
-
Persistent positron emission tomography positivity secondary to benign histiocytic proliferation after treatment of Hodgkin lymphoma.Leuk Lymphoma. 2007 Mar;48(3):616-8. doi: 10.1080/10428190601140058. Leuk Lymphoma. 2007. PMID: 17454607 No abstract available.
-
Combination chemoradiotherapy in early Hodgkin lymphoma.Hematol Oncol Clin North Am. 2014 Feb;28(1):33-47. doi: 10.1016/j.hoc.2013.10.010. Hematol Oncol Clin North Am. 2014. PMID: 24287066 Review.
Cited by
-
Continuum of Care for Hodgkin Lymphoma: Impact of Modern Therapy on Postacute Morbidity and Mortality.J Clin Oncol. 2020 Dec 10;38(35):4131-4134. doi: 10.1200/JCO.20.02668. Epub 2020 Oct 8. J Clin Oncol. 2020. PMID: 33030980 Free PMC article. No abstract available.
-
[Clinical characteristics and survival analysis of pediatric Hodgkin lymphoma: a multicenter study].Zhongguo Dang Dai Er Ke Za Zhi. 2025 Jun 15;27(6):668-674. doi: 10.7499/j.issn.1008-8830.2412144. Zhongguo Dang Dai Er Ke Za Zhi. 2025. PMID: 40583705 Free PMC article. Chinese.
-
Harnessing multi-source data for individualized care in Hodgkin Lymphoma.Blood Rev. 2024 May;65:101170. doi: 10.1016/j.blre.2024.101170. Epub 2024 Jan 14. Blood Rev. 2024. PMID: 38290895 Free PMC article. Review.
References
-
- Moulin-Romsee G, Hindie E, Cuenca X, Brice P, Decaudin D, Benamor M, et al. (18)F-FDG PET/CT bone/bone marrow findings in Hodgkin’s lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging. Eur J Nucl Med Mol Imaging. 2010;37:1095–105. - PubMed
-
- van der Kaaij MA, van Echten-Arends J, Simons AH, Kluin-Nelemans HC. Fertility preservation after chemotherapy for Hodgkin lymphoma. Hematol Oncol. 2010;28:168–79. - PubMed
-
- Bonadonna G, Zucali R, Monfardini S, De Lena M, Uslenghi C. Combination chemotherapy of Hodgkin’s disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP. Cancer. 1975;36:252–9. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical